Imagen de Portada

Integrated Bioinformatics Analysis of Indonesian Herbal Compound Targeting AKT1, EGFR, SRC, and KRAS in Lung Cancer

Fuente: Zenodo

Guardado en:

Detalles Bibliográficos
Autor principal:	Marzelino, Alfa
Formato:	Recurso digital
Publicado:	Zenodo 2026
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Lung adenocarcinoma: Sustained subtyping with immunohistochemistry and EGFR, HER2 and KRAS mutational status
por: Vitor Sousa
Publicado: (2015)

Robust Multicenter CT Radiogenomics for Dual EGFR and KRAS Prediction in Lung Cancer with Stability-Aware Modeling and SHAP Interpretation
por: Mehrnia, Somayeh Sadat, et al.
Publicado: (2026)

Correction to “Trametinib Overcomes KRAS ‐ G12V –Induced Osimertinib Resistance in a Leptomeningeal Carcinomatosis Model of EGFR ‐Mutant Lung Cancer”
Publicado: (2025)

Targeting KRAS in Cancer Therapy: Beyond Inhibitors
por: Chunhui Chen, et al.
Publicado: (2025)

Innovative Pyrazole–Thiazole–Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer Treatment
por: Burak Kuzu, et al.
Publicado: (2025)

Targeting Transient Receptor Potential Melastatin‐2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer
por: Zhen Chen, et al.
Publicado: (2024)

Targeting KRAS in gynecological malignancies
por: Yuanyuan Peng, et al.
Publicado: (2024)

Clinical Outcomes of Different Generation EGFR TKIs in Susceptible EGFR ‐Mutated Advanced Nonsmall‐Cell Lung Cancer
por: Chia‐Yu Kuo, et al.
Publicado: (2025)

Integrating Pharmacokinetics and Pharmacodynamics Modeling with Quantum Regression for Predicting Herbal Compound Toxicity
por: Roosan, Don, et al.
Publicado: (2025)

Le travail des enfants dans les petites exploitations minières du Niger: cas des sites de natron, de sel, de gypse et d'orpaillage
por: Soumaïla Alfa
Publicado: (1999)

Phytochemical Analysis and Anticancer Activity of in Colorectal Cancer: An Integrated Transcriptomic and Bioinformatic Study.
por: Li, Long-Zhu, et al.
Publicado: (2026)

Open Science and Artificial Intelligence for supporting the sustainability of the SRC Network: The espSRC case
por: Garrido, J., et al.
Publicado: (2025)

Identification of Key Targets of Herbal Compounds for Liver Fibrosis Using Network Pharmacology Combined With Transcriptomics
por: Chen Chen, et al.
Publicado: (2026)

Long Short‐Term Memory‐Based Prediction of Indonesian Composite Stock Index Returns for Early Identification of Market Crises
por: Bagus Sartono, et al.
Publicado: (2025)

Targeting Nuclear Receptor Coactivator SRC‐1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD‐L1
por: Yilin Hong, et al.
Publicado: (2024)

Association of 3'UTR variations of EGFR and KRAS oncogenes with clinical parameters in lung cancer tumours
por: Ozkan Bagci
Publicado: (2024)

Taichunamide‐A Inhibits Stomach Cancer Growth Through AKT/MAPK Pathway Suppression and EGFR Inhibitor Synergy
por: Lian‐cheng Xu, et al.
Publicado: (2025)

Highly Specific Cytokine Receptor‐Targeting Chimeras for Targeted Membrane Protein Degradation and Sensitization of Osimertinib in EGFR‐Mutated Non‐Small‐Cell Lung Cancer
por: Jiawei Wu, et al.
Publicado: (2025)

Targeting mutated KRAS in the first‐line therapy
por: Hideaki Ijichi
Publicado: (2024)

Differential Response and Resistance to KRAS‐Targeted Therapy
por: Zhaojin Liu, et al.
Publicado: (2025)

Integration of Bioinformatics and Experiments to Identify Mitochondrial Metabolism and Immune Infiltration Characterization in Lung Injury and Post‐Injury Lung Fibrosis
por: Cong‐cong Chen, et al.
Publicado: (2026)

Clinical Relevance of EGFR in Breast Cancer: Precision Targeting for Better Outcomes
por: Badhe, Pravin
Publicado: (2025)

Lung Cancer: Targets and Therapy
Publicado: (2010)

Synthetic Lethality of SHP2 and XIAP Suppresses Proliferation and Metastasis in KRAS‐mutant Nonsmall Cell Lung Cancer
por: Nai‐jie Fu, et al.
Publicado: (2025)

Carta de retratação
por: Alfa Oumar Diallo
Publicado: (2020)

RENASCIMENTO AFRICANO E DESENVOLVIMENTO
por: Alfa Oumar Diallo
Publicado: (2011)

Comparación de tres pruebas diagnósticas para el aborto por rinotraqueítis infecciosa bovina en hatos lecheros
por: Alfa Bracho Cárdenas
Publicado: (2006)

A nova parceria para o desenvolvimento da África
por: Alfa Oumar Diallo
Publicado: (2008)

Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR Mutation
por: Chang Dong Yeo, et al.
Publicado: (2025)

Comprehensive Bioinformatic Analysis of TONSL Expression in Pan‐Cancer
por: Ying Yang, et al.
Publicado: (2026)

Identification of Hub Genes for Psoriasis and Cancer by Bioinformatic Analysis
por: Yao Yu, et al.
Publicado: (2024)

Journal of Integrative Bioinformatics
Publicado: (2018)

Imidazole–Oxadiazole‐Linked Sulfonyl‐1,2,3‐triazoles as Potential EGFR Inhibitors for Lung Cancer Treatment
por: Venkat Reddy Dodlapati, et al.
Publicado: (2025)

A Comprehensive Review on Potential In Silico Screened Herbal Bioactive Compounds and Host Targets in the Cardiovascular Disease Therapy
por: Elham Zarenezhad, et al.
Publicado: (2024)

Herbal Bioactive Targeting Prostate Cancer: A Network Pharmacology and Molecular Mechanism Perspective
por: Shubham Patil1, Ashok Bendgude2, Siddhi Shirahatti3, Ajit Patil4, Godfrey Mathews5
Publicado: (2026)

EGFR‐TKIs Induced DPP4 Drives Metabolic Reprogramming of Persister Cells in Lung Cancer
por: Yuanzhou Zhang, et al.
Publicado: (2025)

First‐Line Third‐Generation EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR‐Mutated Non‐Small Cell Lung Cancer: A Systematic Review and Network Meta‐Analysis
por: Wei Du, et al.
Publicado: (2025)

An Updated Comprehensive Review of Plants and Herbal Compounds with Antiasthmatic Effect
por: Mohammad Amin Rajizadeh, et al.
Publicado: (2024)

The Mechanism of Scopolamine’s Effect on Migration Function of Lung Cancer Cells: A Network Pharmacology and Bioinformatics Perspective
por: Yang Xiao, et al.
Publicado: (2024)

Aripiprazole as an Inhibitor of the EGFR/PI3K/AKT Signaling Pathway and Sensitizer of MPA Suppressed Progestin‐Resistant Endometrial Cancer Cells
por: Wen Gan, et al.
Publicado: (2025)